Results 151 to 160 of about 13,200 (250)

Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains. [PDF]

ACS Chem Neurosci
Oasa S, Mak WH, Maddox AL, Lima C, Saftics A, Terenius L, Jovanović-Talisman T, Vukojević V.   +7 more
europepmc   +1 more source

Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report. [PDF]

Addict Sci Clin Pract
Azar P, Machado J, Kim JJ, Wong JSH, Nikoo M, Li VW.   +5 more
europepmc   +1 more source

Methocinnamox is a Potent and Long-Acting Antagonist that can Prevent and Reverse Opioid-Induced Respiratory Depression. [PDF]

J Pharmacol Exp Ther
Carr JA, Morgan DJ.
europepmc   +1 more source

Pharmacotherapy II: narcotic and narcotic-antagonists analgesics.

, 1978
Gardier Rw
openalex   +1 more source

Studies on the assesment of analgesic actions of narcotic antagonists with special reference to nociception induced by retrograde injection of bradykinin into the carotid artery of rat.

, 1971
Takeshi Abe, Takeru Kaneko, Hiroshi Takagi   +2 more
openalex   +2 more sources

A protocol for a randomized comparison of extended-release versus sublingual buprenorphine among pre-trial detainees in jail. [PDF]

Addict Sci Clin Pract
Rottapel RE, Stopka TJ, Friedmann PD, Hoskinson RA, Englander D, Calhoun N, Senst T, Gudas C, Koutoujian PJ, Farabee D.   +9 more
europepmc   +1 more source

Carfentanil stabilizes µ opioid receptor conformations that are ultra-efficient in inhibiting cAMP, resistant to naloxone or nalmefene but sensitive to naltrexone. [PDF]

Arch Toxicol
Endt F, Guo T, Steinritz D, Amend N, Gudermann T, Breit A.   +5 more
europepmc   +1 more source

Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.

Health Technol Assess
Snooks H, Benger J, Bell F, Black S, Dixon S, Emery H, Evans BA, Fuller G, Hoskins R, Hughes J, Jones J, Jones M, Johnston S, Long J, Moore C, Parab R, Pilbery R, Sampson FC, Watkins A.   +18 more
europepmc   +1 more source

Predictors of naltrexone prescribing for alcohol use disorder from the emergency department. [PDF]

Alcohol Clin Exp Res (Hoboken)
Lebin JA, Hensen C, Lun Z, Kwan BM, Goldberg EM, Burnham EL, Hoppe JA.   +6 more
europepmc   +1 more source

Seeing the bigger picture: endogenous opioids mediate attentional broadening after reward receipt. [PDF]

Psychol Med
van Steenbergen H, Gable P, Fagan H, Molteni L, Midveris A, Huneke N.   +5 more
europepmc   +1 more source